No Image

ExThera Medical: Will Its Seraph™ Device Eliminate Bacteremia and Prevent Sepsis at Point-of-Care?

December 13, 2012 OneMedPlace Team 0

The first start-up by Bob Ward—The Polymer Technology Group (PTG)—earned a 555X return for investors upon its sale in 2008 to DSM, the global life sciences and materials company. Now, Bob Ward’s swinging away at another potential homerun: ExThera Medical, a Berkeley, California-based company, with its scientific origins at the Karolinska Institute in Stockholm, Sweden.

No Image

Bulls, Bears: Sepsis and Anti-Infectives in the Public Markets

September 28, 2012 OneMedPlace Team 0

The threat of infection in hospital and other treatment facilities have dramatically increased over the last few years. Antibiotics and other therapies have become impotent against certain pathogens and infections, increasing the need for research funding for creating new antibiotics. These three companies have the potential to solve a significant unmet medical need.